20th Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2018

$40

Course details

Session 1: Valve Disease – Focus on Aortic Stenosis I

Aortic Stenosis: What Criteria Directs Which Treatment?	David Rubenson, MD, FACC, FASE
Mechanism of Aortic Stenosis: Degenerative, Atherosclerosis, or Inflammation	Gian M. Novaro, MD, FACC, FASE
TAVR Is a Team Sport: The Dynamics of the Heart Valve Team	Stephanie Mick, MD
3D Echo and MDCT Imaging for TAVR	Milind Desai, MD
Is TAVR Applicable in Lower Risk Groups?	Jonathon White, MD
Paravalvular Regurgitation in TAVR: Prediction, Prevention, Quantitation and Management	Linda Gillam, MD, MPH, FACC, FASE, FESC
Valve in Valve TAVR – Another Plus for Bioprostheses at First Operation?	Robert Cubeddu, MD

Session 2: Valve Disease—Focus on Aortic Stenosis II

Intraprocedural TEE in SAVR and TAVR: Incremental Benefit or Essential Tool?	Linda Gillam, MD, MPH, FACC, FASE, FESC
Thoracic Aortic Disease – When CT, MR, TTE, TEE?	Milind Desai, MD
Ascending Aortic Dilation – A Concomitant of Aortic Valve Disease	Gian M. Novaro, MD, FACC, FASE
Paradoxical or Not: Low Flow, Low Gradient Aortic Stenosis (AS)	William J. Stewart, MD, FACC, FASE
Transcatheter Procedures – What to Do When the Awful Happens	Jonathon White, MD
Dobutamine Echo in Aortic Stenosis – Indications, Methods, Impact on Management	Brian Griffin, MD, FACC
Panel Discussion

Session 3: Aortic Stenosis Case Workshop

How to Do an AS Exam For Sonographers	Deborah A. Agler, ACS, RDCS, FASE
Management of TAVR Paravalvular Leak	Robert Cubeddu, MD
AS, HOCM, or Not?	Milind Desai, MD
Watchman LAA Closure	Konstantinos P. Koulogiannis, MD
Severe Aortic Stenosis	Stephanie Mick, MD

Session 4: Diastolic Dysfunction and Right Heart Function I

Updated Guidelines for Assessment of LV Filling Pressure	Sherif Nagueh, MD
Practical Approach to Diastolic Function: Limitations and Pitfalls	Deborah A. Agler, ACS, RDCS, FASE
Estimating LV Filling Pressures By Echocardiography	Milind Desai, MD
Constriction and Amyloid: Diastolic Dysfunction	Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Diastolic Dysfunction and LVOT Gradients in Hypertrophic Cardiomyopathy	Sherif Nagueh, MD
Hemodynamic Correlates of Diastolic Dysfunction: What do the Studies Show?	Sherif Nagueh, MD
Diastolic Dysfunction in Special Populations: Atrial Fibrillation, MV Disease, Transplant, Pulmonary Hypertension	William J. Stewart, MD, FACC, FASE
Panel Discussion

Session 5: Diastolic Dysfunction and Right Heart Function II

Athletic Heart vs. Varied Faces of Hypertrophic Cardiomyopathy	Milind Desai, MD
Complicated Pericarditis: A New Imaging Guided Approach	Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Clinical Presentation of Right Sided Heart Disease – “Look-alikes”	Linda Gillam, MD, MPH, FACC, FASE, FESC
Tricuspid Valve Dysfunction- Subtypes and Outcomes	David Rubenson, MD, FACC, FASE
Aortic Valve: Replace, Repair?	Stephanie Mick, MD
Transcatheter Tricuspid Interventions: The Forgotten Valve No Longer!	Hector I. Michalena, MD, FACC, FASE
Role of Contrast Echo in Assessing Left and Right Heart Function	Deborah A. Agler, ACS, RDCS, FASE
Panel Discussion

Session 6: Constriction, Restriction, Tricuspid Regurgitation and Contrast Echo Cases

Tricuspid Valve 1	Konstantinos P. Koulogiannis, MD
HOCM	Deborah A. Agler, ACS, RDCS, FASE
Multivalve Disease	David Rubenson, MD, FACC, FASE
Severe Symptomatic TR	Brian Griffin, MD, FACC
Diastolic Heart Failure	Robert Cubeddu, MD
Percutaneous Valvuloplasty For Mitral Stenosis	Sherif Nagueh, MD
Cardio Oncology	Diego Sadler, MD, FACC, FACP
Functional Tricuspid Regurgitation	William J. Stewart, MD, FACC, FASE
Tricuspid Valve 2	Konstantinos P. Koulogiannis, MD

Session 7: Valve Regurgitation, 3D Echo and Strain I

State of the Art Echo Quantification of Mitral and Aortic Regurgitation	Linda Gillam, MD, MPH, FACC, FASE, FESC
Aortic Regurgitation – Decisions Based on Clinical and Echo Data	Brian Griffin, MD, FACC
Surgical Considerations in Mitral Regurgitation	Stephanie Mick, MD
Asymptomatic Severe Mitral Regurgitation: Choosing the Golden Moment	William J. Stewart, MD, FACC, FASE
Exercise Testing in Mitral or Aortic Valve Disease: What do the Guidelines Say?	David Rubenson, MD, FACC, FASE
Mitraclip: The New Mitral Repair	Hector Michalena, MD, FACC, FASE
Percutaneous Mitral and Tricuspid Valve Therapies and Paravalvular Leak Closure	Jonathon White, MD
Panel Discussion

Session 8: Valve Regurgitation, 3D Echo and Strain II

Incorporating 3D Echo and LV Strain into Routine Practice in the Echo Lab	Deborah A. Agler, ACS, RDCS, FASE
3D Echo: How to Acquire Data with Each of 3 Vendors	Konstantinos P. Koulogiannis, MD
Unique Skills of 3D Echo over 2D: Which Situations?	William J. Stewart, MD, FACC, FASE
Myocardial Mechanics: Strain and Torsion in Clinical Practice	Sherif Nagueh, MD
LV Strain in Cardio-Oncology	Diego Sadler, MD, FACC, FACP
Muscle Mechanics in Pericardial Disease	Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Panel Discussion

Session 9: Radiation, Contrast Echo and MR Treatment Cases

Newer Treatment Options For Recurrent Pericarditis	Chandra Kanth Ala, MD
Transcatheter Mitral Valve Replacement	Cliff Chun Pong Wong, MD
Will I Get Better With Heart Surgery?	Beni R. Verma, MD
Valvular Heart Disease	Konstantinos P. Koulogiannis, MD
P2 Prolapse Repair	Brian Griffin, MD, FACC